Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Cyclo Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 397.8K | 1.29M | +889.1K (+223.5%) |
| Value | $768.0K | $1.83M | +$1.06M (+137.9%) |
New holders (4)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 930,000 | $1.32M | 0.04% |
| UBS Group AG | 2,810 | $3.99K | 0.00% |
| Bank of America Corp | 18 | $26 | 0.00% |
| Princeton Global Asset Management LLC | 300 | $0 | 0.00% |
Sold out (1)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Renaissance Technologies LLC | 48,494 | $94.0K |